LONDON (Alliance News) – British & American Investment Trust PLC, Biotech Growth Trust PLC, and International Biotechnology Trust PLC were among the best-performing London-listed investment companies in May, according to research firm QuotedData, which said there was a “small rally” in the biotech and healthcare sector that month. You can read the rest of the […]
Pacific Horizon – investor in Asian growth Marten and Co publishes its first initiation of coverage note on Pacific Horizon (PHI) The company is unashamedly a growth fund and its Asia-focused portfolio has significant overweight exposures to technology and biotechnology. However, it would appear that, investors are shying away from Asia because of weak Chinese growth and […]
Please click on the link above to access our initiation note on Pacific Horizon. Pacific Horizon (PHI) is unashamedly a growth fund and its Asia-focused portfolio has significant overweight exposures to technology and biotechnology. However, it would appear that, investors are shying away from Asia because of weak Chinese growth and are seeking safety in […]
Jupiter US Smaller Companies underperformed its benchmark over the year to the end of June 2015 – generating an uplift in net assets of 5.5% against a 14.3% return on the Russell 2000 Index. The main reasons were the absence of biotechnology stocks in the portfolio and falls in the values of the fund’s investments in […]
Final results for The North American Income Trust for the year that ended 31 January 2014 show the fund delivering an 18.9% return on net assets, which isn’t bad but does lag the 25.0% return on the S&P500 Index by some margin. The fund’s discount widened from 5% to 7.9% over the year and so […]
International Biotechnology Trust tries to achieve long-term capital growth by investing primarily in biotechnology and other life sciences companies that are either quoted or unquoted and possess the potential for high growth. International Biotechnology Trust invests in companies whose shares are considered to have good prospects, with experienced management and strong potential upside through the development and/or […]
Results for the year ended 30 September 2013 PCGH’s NAV total return was 21.0%, adjusted for the likely impact of PCGH’s subscription shares being exercised, and 23.2% without making that adjustment. The benchmark, the MSCI All Countries World Index Healthcare Index, returned 25.4%. The Board say that the main reason for the underperformance relative to the […]
July 2024 Monthly | Investment companies Kindly sponsored by abrdn Winners and losers in June 2024 There were a handful of major catalysts driving global markets in June. We saw the AI phenomenon reach a new peak, with Nvidia briefly becoming the largest company in the world by market cap on June 19th, hitting a […]
In the US, hopes for near-term interest rate cuts may have been dashed by the Federal Reserve (Fed). In a recent speech, governor Lisa Cook noted that services inflation was running above pre-pandemic levels. She forecast that forecast ‘that three- and six-month inflation rates will continue to move lower on a bumpy path’, but thinks […]
Heralding in the age of AI In a world where AI stocks have determined the fortunes of global equity markets, Herald Investment Trust (HRI) offers a way to capitalise on these potent tailwinds while still offering an arguably seldom-found discount opportunity within a universe known for its high valuations, coupled with the trust currently trading […]
Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.
Due to data protection policies, USA residents can not access our data.
Your content has been curated
